CHU Felix Guyon

Saint-Denis, La Réunion

0 studies enrolling now · 1 studies all time

What they study most

Lupus Erythematosus, Systemic

Studies at this site

• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed